FDA Delays Action on CBD

On March 10, the U.S. Food and Drug Administration (FDA) announced that it will reopen the comment period for last year’s CBD hearing. The original comment period, which collected nearly 4,500 comments from public health experts, the natural products industry and the general public, ended last July and will remain open indefinitely, according to the FDA. ...